Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exagen

3.75
+0.13003.59%
Volume:44.00K
Turnover:160.93K
Market Cap:67.12M
PE:-4.52
High:3.79
Open:3.62
Low:3.44
Close:3.62
Loading ...

Exagen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
04 Jan

Exagen price target raised to $7 from $5 at Canaccord

TIPRANKS
·
03 Jan

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

GlobeNewswire
·
12 Dec 2024

Data Storage And 2 Other US Penny Stocks To Watch

Simply Wall St.
·
11 Dec 2024

Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
15 Nov 2024

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the Avise® Ctd Platform

THOMSON REUTERS
·
15 Nov 2024

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

GlobeNewswire
·
15 Nov 2024

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

GlobeNewswire
·
14 Nov 2024

Exagen’s Strategic Advancements and Market Potential Drive Buy Rating Amidst Upcoming ADVISE Test Launch

TIPRANKS
·
13 Nov 2024

Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

GuruFocus.com
·
13 Nov 2024

Q3 2024 Exagen Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024

Exagen Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

Exagen Inc: Outlook FY24 REV $55 Mln to $56 Mln

THOMSON REUTERS
·
12 Nov 2024

Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates

Zacks
·
12 Nov 2024

Exagen Q3 EPS $(0.28) Beats $(0.29) Estimate, Sales $12.51M Miss $13.56M Estimate

Benzinga
·
12 Nov 2024

Exagen Inc: Reiterates 2024 Adjusted Ebitda Loss Expectations of Better Than $12 Mln

THOMSON REUTERS
·
12 Nov 2024